Actively Recruiting
Evaluation of Improvements in Patient-reported Quality of Life
Led by Fundación para la Investigación del Hospital Clínico de Valencia · Updated on 2025-08-06
110
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning supported by REBECCA-collected real-world data, in comparison with standard care
CONDITIONS
Official Title
Evaluation of Improvements in Patient-reported Quality of Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent given before registration
- Histologically confirmed stage I-III breast cancer with endocrine treatment started no more than 12 months before randomization
- Age between 18 and 75 years
- Life expectancy longer than 3 months after treatment start
- Ability to understand study procedures and willingness to sign consent
- No psychological, familial, sociological, or geographical issues that would prevent following the study protocol and schedule
You will not qualify if you...
- Unwillingness to sign an informed consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clínico Universitario de Valencia
Valencia, Spain, 46010
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here